← back to search

Dipen J. Parekh

University of Miami · US
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Bladder and Urothelial Cancer Treatments, Prostate Cancer Treatment and Research, and Renal cell carcinoma treatment.
h-index
45
citations
9,930
works
373
NIH funding
primary concept
email

Recent publications

Racial and Ethnic Disparities in the Utilization of Partial Nephrectomy and Robotic Surgery for Renal Cell Carcinoma
JU Open Plus 2026cited by 3position: middledoi
Improved Consistency of <i>Candida auris</i> Colonization Screening With an Anterior Nares and Hands Composite Sample
Clinical Infectious Diseases 2025cited by 9position: middledoi
Comparison of Complication and Readmission Rates Between Robot-Assisted and Open Radical Cystectomy: Results From the Randomized RAZOR Clinical Trial
The Journal of Urology 2025cited by 5position: middledoi
Application of Natural Language Processing in Electronic Health Record Data Extraction for Navigating Prostate Cancer Care: A Narrative Review
Journal of Endourology 2024cited by 13position: middledoi
Factors Associated With Poor Clinical and Microbiologic Outcomes in <i>Candida auris</i> Bloodstream Infection: A Multicenter Retrospective Cohort Study
Clinical Infectious Diseases 2024cited by 10position: middledoi
Evaluating 4Kscore’s role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS score
Prostate Cancer and Prostatic Diseases 2024cited by 6position: middledoi
Changing times: trends in risk classification, tumor upstaging, and positive surgical margins after radical prostatectomy - results from a contemporary National Cancer Database study
World Journal of Urology 2024cited by 4position: middledoi
Impact of BMI Category on Recurrence and Progression of Nonmuscle Invasive Bladder Cancer Prognosis
Clinical Genitourinary Cancer 2024cited by 2position: middledoi
HRS Improves Active Surveillance for Prostate Cancer by Timely Identification of Progression
Academic Radiology 2024cited by 2position: middledoi
Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Controlled Trials
European Urology 2023cited by 98position: middledoi
Persistent colonization of <i>Candida auris</i> among inpatients rescreened as part of a weekly surveillance program
Infection Control and Hospital Epidemiology 2023cited by 14position: middledoi
Incidental prostate cancer after holmium laser enucleation of the prostate: Critical analysis of independent risk factors and impact on surgical outcomes
BJUI Compass 2023cited by 11position: middledoi
Operational impact of decreased turnaround times for <i>Candida auris</i> screening tests in a tertiary academic medical center
Antimicrobial Stewardship & Healthcare Epidemiology 2023cited by 7position: middledoi
Corrigendum to “Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Controlled Trials” [Eur Urol. 2023;84:393–405]
European Urology 2023cited by 3position: middledoi
Comparison of Robot-Assisted and Open Radical Cystectomy in Recovery of Patient-Reported and Performance-Related Measures of Independence
JAMA Network Open 2022cited by 22position: lastdoi
Bloodstream Infection Risk, Incidence, and Deaths for Hospitalized Patients during Coronavirus Disease Pandemic
Emerging infectious diseases 2021cited by 32position: middledoi
Surveillance Intensity in Intermediate Risk, Nonmuscle Invasive Bladder Cancer: Revisiting the Optimal Timing and Frequency of Cystoscopy
The Journal of Urology 2021cited by 21position: middledoi
Impact of Plant-Based Diet on PSA Level: Data From the National Health and Nutrition Examination Survey
Urology 2021cited by 19position: middledoi
Prostatic Ductal Adenocarcinoma Controlled for Tumor Grade, Stage, and Margin Status Does Not Independently Influence the Likelihood of Biochemical Recurrence in Localized Prostate Cancer After Radical Prostatectomy
Archives of Pathology & Laboratory Medicine 2021cited by 12position: middledoi
Linking prediction models to government ordinances to support hospital operations during the COVID-19 pandemic
BMJ Health & Care Informatics 2021cited by 11position: middledoi
Surgery for Bladder and Upper Tract Urothelial Cancer
Hematology/Oncology Clinics of North America 2021cited by 8position: lastdoi
Prospective Evaluation of Focal High Intensity Focused Ultrasound for Localized Prostate Cancer
The Journal of Urology 2020cited by 35position: lastdoi
Health Related Quality of Life of Patients with Bladder Cancer in the RAZOR Trial: A Multi-Institutional Randomized Trial Comparing Robot versus Open Radical Cystectomy
The Journal of Urology 2020cited by 34position: lastdoi
Predicting intra‐operative and postoperative consequential events using machine‐learning techniques in patients undergoing robot‐assisted partial nephrectomy: a Vattikuti Collective Quality Initiative database study
British Journal of Urology 2020cited by 28position: middledoi
A 4Kscore Cut-off of 7.5% for Prostate Biopsy Decisions Provides High Sensitivity and Negative Predictive Value for Significant Prostate Cancer
Urology 2020cited by 18position: middledoi
Performance of Multiparametric MRI of the Prostate in Biopsy Naïve Men: A Meta-analysis of Prospective Studies
Urology 2020cited by 13position: middledoi
Use and Validation of the AUA/SUO Risk Grouping for Nonmuscle Invasive Bladder Cancer in a Contemporary Cohort
The Journal of Urology 2019cited by 118position: middledoi
Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup
The Journal of Urology 2019cited by 115position: lastdoi
Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases
World Journal of Urology 2019cited by 36position: middledoi
Androgen Suppression Therapy Is Associated with Lower Recurrence of Non–muscle-invasive Bladder Cancer
European Urology Focus 2019cited by 23position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mark L. Gonzalgo · University of Miami26 papers (2014–2026)Chad R. Ritch · University of Miami21 papers (2017–2024)Sanoj Punnen · University of Miami20 papers (2016–2024)Nachiketh Soodana‐Prakash · University of Miami19 papers (2016–2024)Sanoj Punnen · University of Miami13 papers (2014–2024)Bruno Nahar · University of Miami13 papers (2016–2024)Vivek Venkatramani · University of Miami11 papers (2017–2022)Bruce Kava · University of Miami8 papers (2016–2024)Oleksandr N. Kryvenko · University of Miami7 papers (2016–2024)Maria C. Velasquez · University of California, San Francisco6 papers (2017–2024)Bhavarth Shukla · University of Miami6 papers (2021–2025)Mahmoud Alameddine · Ottumwa Regional Health Center6 papers (2017–2020)Maria F. Becerra · Catholic University of the Maule5 papers (2019–2021)Radka Stoyanova · University of Miami5 papers (2016–2024)Deukwoo Kwon · University of Arkansas for Medical Sciences5 papers (2018–2021)Hayley B. Gershengorn · Albert Einstein College of Medicine5 papers (2021–2024)Tulay Koru‐Sengul · University of Miami5 papers (2017–2019)Isildinha M. Reis · University of Miami5 papers (2015–2024)Alan Pollack · University of Miami5 papers (2016–2019)Sebastian Arenas · University of Miami5 papers (2021–2025)